Two Sigma Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,500
| Closed | -$2.96M | – | 2576 |
|
|
2024
Q4 | $2.96M | Sell |
53,500
-202,900
| -79% | -$11.2M | 0.01% | 938 |
|
|
2024
Q3 | $8.43M | Sell |
256,400
-51,200
| -17% | -$1.68M | 0.02% | 532 |
|
|
2024
Q2 | $8.36M | Buy |
307,600
+233,700
| +316% | +$6.35M | 0.02% | 593 |
|
|
2024
Q1 | $2.69M | Buy |
73,900
+7,600
| +11% | +$276K | 0.01% | 1069 |
|
|
2023
Q4 | $1.34M | Buy |
66,300
+5,200
| +9% | +$105K | ﹤0.01% | 1489 |
|
|
2023
Q3 | $1.09M | Buy |
61,100
+30,800
| +102% | +$547K | ﹤0.01% | 1483 |
|
|
2023
Q2 | $548K | Buy |
+30,300
| New | +$548K | ﹤0.01% | 1778 |
|
|
2023
Q1 | – | Sell |
-26,700
| Closed | -$391K | – | 2746 |
|
|
2022
Q4 | $391K | Sell |
26,700
-5,400
| -17% | -$79.2K | ﹤0.01% | 1973 |
|
|
2022
Q3 | $550K | Buy |
32,100
+21,500
| +203% | +$368K | ﹤0.01% | 1805 |
|
|
2022
Q2 | $155K | Buy |
+10,600
| New | +$155K | ﹤0.01% | 2326 |
|